Exosome Diagnostics Inc-Medical Equipment-Deals and Alliances Profile

Exosome Diagnostics Inc-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME103113D
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. It offers liquid biopsy tests kits, EXO50 kits, EXO60 kits and EXO70 kits. Exosome Diagnostics' services comprise miRNA profiling, mRNA profiling, mutation detection, and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

Exosome Diagnostics Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Exosome Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Exosome Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Exosome Diagnostics Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Exosome Diagnostics Raises USD60 Million in Series B Financing Round 12

Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 13

Exosome Diagnostics Raises USD1.5 Million in Financing Round 14

Exosome Diagnostics to Raise USD25 Million in Venture Financing 14

Exosome Diagnostics Raises US$27 Million In Series B Financing Round 15

Exosome Diagnostics Raises US$7 Million In Venture Financing 16

Partnerships 17

Exosome Diagnostics Enters into Agreement with Merck 17

Exosome Diagnostics Enters into Agreement with Amgen 18

Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 18

Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 19

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 20

Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 21

Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 22

Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 23

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 24

Exosome Diagnostics Inc-Key Competitors 26

Key Employees 27

Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Corporate Communications 29

Sep 13, 2016: Exosome Diagnostics Appoints Elizabeth Cormier-May as Head of Commercial Diagnostics 29

Jun 27, 2016: Exosome Diagnostics Appoints Mario Morken as Director of Business Development 30

Jun 06, 2016: Exosome Diagnostics Announces Key Appointments to Informatics Group 31

May 23, 2016: Exosome Diagnostics Appoints John Healy as Vice President of Informatics 32

Jan 13, 2016: Leading Liquid Biopsy Company, Exosome Diagnostics, Appoints Daniel Zabrowski as Board Member 33

Legal and Regulatory 34

Jan 18, 2017: Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory 34

Product News 35

Jun 22, 2017: Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention 35

Nov 10, 2016: Exosome Diagnostics Unveils Novel Platform for Detection of Clinically Relevant Biomarkers 36

Jun 08, 2016: Exosome Diagnostics Presents Data on Novel Platform for Disease-Specific Exosomes 37

May 12, 2016: Exosome Diagnostics Discovers World's First Kidney Transplant Rejection Signature from a Simple Urine Test 38

Jan 26, 2016: ExoDx Prostate(IntelliScore): A More Precise, Genetically Informed Prostate Cancer Test from a Simple Urine Sample 39

Jan 21, 2016: Exosome Diagnostics Launches World's First Exosomal RNA-Based Liquid Biopsy, ExoDx Lung(ALK) 40

Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Exosome Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Exosome Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Exosome Diagnostics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Exosome Diagnostics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Exosome Diagnostics Inc, Medical Equipment, Key Facts 1

Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Exosome Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Exosome Diagnostics Inc, Deals By Market, 2011 to YTD 2017 9

Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Exosome Diagnostics Raises USD60 Million in Series B Financing Round 12

Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 13

Exosome Diagnostics Raises USD1.5 Million in Financing Round 14

Exosome Diagnostics to Raise USD25 Million in Venture Financing 14

Exosome Diagnostics Raises US$27 Million In Series B Financing Round 15

Exosome Diagnostics Raises US$7 Million In Venture Financing 16

Exosome Diagnostics Enters into Agreement with Merck 17

Exosome Diagnostics Enters into Agreement with Amgen 18

Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 18

Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 19

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 20

Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 21

Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 22

Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 23

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 24

Exosome Diagnostics Inc, Key Competitors 26

Exosome Diagnostics Inc, Key Employees 27

Exosome Diagnostics Inc, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Exosome Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16090
Site License
USD 500 INR 32180
Corporate User License
USD 750 INR 48270

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com